Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.2769
-0.0280 (-9.18%)
At close: Dec 10, 2025, 4:00 PM EST
0.2778
+0.0009 (0.33%)
After-hours: Dec 10, 2025, 7:57 PM EST
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $15.68 million as of December 10, 2025. Its market cap has increased by 440.85% in one year.
Market Cap
15.68M
Enterprise Value
9.38M
1-Year Change
440.85%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $15.68M, a decrease of -54.40%. That is a compound annual growth rate of -14.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 17.30M | 496.55% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |